ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Qiagen N.V. (QGEN)

NYSE · Common stock

$48.22-0.68 (-1.39%)

As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow QGEN in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on QGEN and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free QGEN chart →

QGEN at a glance

Key statistics

$10.10B

Market capitalization

Previous close
$48.90
Open
$48.10
Day range
$47.95 – $49.02
Volume
3.68M
Average volume (30 sessions)
2.31M
Shares outstanding
206.07M
Beta (1 year, vs SPY)
0.45

Where the price sits in its year

52-week range

62% of the range

Below the 52-week high
-16.6%
Above the 52-week low
+48.2%

Completed sessions through Oct 20, 2026

Technical snapshot

Above its 50-day and 200-day averages

20-day average
$45.13+8.4%
50-day average
$43.99+11.2%
200-day average
$42.48+15.1%
RSI (14)70.4

In the band above 70 that convention calls overbought. Strong trends can stay there for weeks.

+7.6%

1 week

+9.2%

1 month

+20.5%

3 months

+8.7%

Year to date

+1.3%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with QGEN

From the public news wire

QGEN headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →
  • QIAGEN NV

    +10.0K

    10% owner · Open-market purchase

    $13.50K · Jun 15, 2007

  • QIAGEN NV

    +10.0K

    10% owner · Open-market purchase

    $12.90K · Jun 12, 2007

  • QIAGEN NV

    +50.0K

    10% owner · Open-market purchase

    $65.50K · Jun 4, 2007

  • QIAGEN NV

    +5.0K

    10% owner · Open-market purchase

    $6.55K · May 31, 2007

  • QIAGEN NV

    +10.0K

    10% owner · Open-market purchase

    $13.10K · May 29, 2007

  • QIAGEN NV

    +30.0K

    10% owner · Open-market purchase

    $39.30K · May 30, 2007

  • QIAGEN NV

    +17.5K

    10% owner · Open-market purchase

    $22.57K · May 23, 2007

  • QIAGEN NV

    −240.0K

    10% owner · Option exercise

    · May 9, 2007

About Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Exchange
NYSE
Security
Common stock
Employees
5,500
Listed since
Jun 28, 1996
Website
qiagen.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.